Jesse McCall, MBA, is currently a Director and Improvement Advisor at the Institute for Healthcare Improvement (IHI). Jesse joined IHI in 2007 and over his tenure has designed, executed, and evaluated programs and projects around the world. Outside of IHI Jesse is a Teaching Fellow at Harvard University, specifically on courses related to the Science of Improvement. Jesse has expertise in program and product development, practical application of the science of improvement, human capital management, marketing and communications, customer relationship management, and large-scale initiative operations. He received his undergraduate degree in Business Administration from Northeastern University in Boston and his MBA at the UMass Amherst Isenberg School of Management.
Erwin Palomino, an Improvement Advisor at the Institute for Healthcare Improvement, has more than 25 years of experience applying process improvement methodology across global corporations. He is black belt certified in business process improvement by Dell Technologies (six-sigma equivalent), where he not only applied improvement and lean methodologies to solve complex problems but also coached dozens of teams in the use of improvement science in their daily work. Mr. Palomino holds an Engineering degree, an MBA, and is a certified Program Manager Professional (PMP). Mr. Palomino’s experience brings a wealth of knowledge to the health care industry not only in the teaching of improvement science but also in the practical application of improvement methods to real life processes in different industries.
Disclaimer: Consistent with the IHI’s policy, faculty for this program are expected to disclose at the beginning of their presentation(s) any economic or other personal interests that create, or may be perceived as creating, a conflict related to the material discussed. The intent of this disclosure is not to prevent a speaker with a significant financial or other relationship from making a presentation, but rather to provide listeners with information on which they can make their own judgments.
Unless otherwise noted below, each presenter provided full disclosure information, does not intend to discuss an unapproved/investigative use of a commercial product/device, and has no significant financial relationship(s) to disclose. If unapproved uses of products are discussed, presenters are expected to disclose this to participants.